Ovarian Cancer

Most ovarian cancers are either ovarian epithelial carcinomas (cancer that begins in the cells on the surface of the ovary) or malignant germ cell tumors (cancer that begins in egg cells). Women who have a family history of ovarian cancer are at an increased risk of developing ovarian cancer. Hereditary ovarian cancer makes up approximately 5 to 10 percent of all cases of ovarian cancer. Three hereditary patterns have been identified: ovarian cancer alone, ovarian and breast cancers and ovarian and colon cancers. Ovarian cancer is hard to detect early because there usually are no symptoms and those symptoms that do occur tend to be vague. The National Cancer Institute estimated 21,650 new cases in 2008

Company Product Phase  
Johnson & Johnson Doxil / Caelyx (pegylated liposomal doxorubicin hydrochloride) M Ovarian Cancer
Genentech, Inc. Avastin (First Line Therapy) III Ovarian Cancer
Genentech, Inc. Avastin (Second Line Therapy) III Ovarian Cancer
Genentech, Inc. Avastin with Gemcitabine and Cisplatin III Ovarian Cancer
Genentech, Inc. Tarceva III Ovarian Cancer
Telik Inc Telcyta III Ovarian Cancer
Telik Inc Telcyta with Carboplatin III Ovarian Cancer
Telik Inc Telcyta with Doxil III Ovarian Cancer
Telik Inc Telcyta with Doxorubicin (Second-Line Therapy) III Ovarian Cancer
Telik Inc Telcyta with Doxorubicin, Topotecan (Third Line Therapy) III Ovarian Cancer
Abraxis BioScience Inc Abraxane II Ovarian Cancer
Amgen Inc AMG386 II Ovarian Cancer
Genentech, Inc. Avastin with Abraxane II Ovarian Cancer
Abraxis BioScience, Inc. Avastin with Abraxane II Ovarian Cancer
Genentech, Inc. Avastin with Erlotinib II Ovarian Cancer
Genentech, Inc. Avastin with Gemcitabine and Oxaliplatin II Ovarian Cancer
Genentech, Inc. Avastin with Paclitaxel and Cisplatin II Ovarian Cancer
Genentech, Inc. Avastin with Taxol and Carboplatin II Ovarian Cancer
BiPar Sciences Inc BSI201 II Ovarian Cancer
BiPar Sciences, Inc. BSI201 with Topotecan II Ovarian Cancer
Genentech, Inc. Doxil with Avastin II Ovarian Cancer
Genentech, Inc. GDC0449 II Ovarian Cancer
Facet Biotech Corporation M200 II Ovarian Cancer
Facet Biotech Corporation M200 with Doxorubicin II Ovarian Cancer
Onyx Pharmaceuticals Inc Nexavar II Ovarian Cancer
Nektar Therapeutics NKTR102 II Ovarian Cancer
Genentech Inc Omnitarg with Gemcitabine II Ovarian Cancer
Cytokinetics Inc SB715992 (Second Line Therapy) II Ovarian Cancer
Sunesis Pharmaceuticals Inc SNS595 II Ovarian Cancer
Sunesis Pharmaceuticals Inc Voreloxin II Ovarian Cancer
OXiGENE INC Zybrestat with Paclitaxel and Carboplatin II Ovarian Cancer

Pancreatic Cancer

Pancreatic cancer has been called a "silent" disease because early pancreatic cancer usually does not cause symptoms. If the tumor blocks the common bile duct and bile cannot pass into the digestive system, the skin and whites of the eyes may become yellow (jaundiced) and the urine darker as a result of accumulated bile pigment called bilirubin. Cancer of the pancreas has markedly increased in incidence over the decades and now ranks as the fourth leading cause of cancer death in the U.S. According to the National Cancer Institute, there were about 37,680 new cases in 2008

Company Product Phase  
Genentech Inc Tarceva with Gemcitabine M Pancreatic Cancer
Abraxis BioScience, Inc. Abraxane with gemcitabine (First Line Therapy) III Pancreatic Cancer
Regulon, Inc Lipoplatin with gemcitabine III Pancreatic Cancer
SuperGen Inc Orathecin with Gemcitabine III Pancreatic Cancer
Amgen Inc AMG655 II Pancreatic Cancer
Genentech, Inc. Avastin and Tarceva with Radiation Therapy II Pancreatic Cancer
Genentech, Inc. Avastin with 5-Fluorouracil, Oxaliplatin, Gemcitabine and External Beam Radiation Therapy II Pancreatic Cancer
Genentech, Inc. Avastin with Gemcitabine and Oxaliplatin (First Line Therapy) II Pancreatic Cancer
Genentech, Inc. Avastin, Gemcitabine with Radiation Therapy II Pancreatic Cancer
BiPar Sciences Inc BSI-201 with Gemcitabine II Pancreatic Cancer
Tragara Pharmaceuticals, Inc. Capoxigem with Gemcitabine and Erlotinib II Pancreatic Cancer
Threshold Pharmaceuticals Inc Glufosfamide, Gemcitabine II Pancreatic Cancer
KangLaiTe USA Inc Kanglaite with Gemcitabine II Pancreatic Cancer
Regulon, Inc Lipoxal II Pancreatic Cancer
Facet Biotech Corporation M200 with Gemcitabine II Pancreatic Cancer
Onyx Pharmaceuticals Inc Nexavar II Pancreatic Cancer
Onyx Pharmaceuticals Inc w/ Bayer Healthcare Pharmaceuticals Nexavar with Gemcitabine II Pancreatic Cancer
Advantagene Inc PancAtak II Pancreatic Cancer